Lei Wang

30PUBLICATIONS
14CO-AUTHORS
PharmacogenomicsProteins and peptidesHaematologyCancer therapy (excl. chemotherapy and radiation therapy)Preventative health care
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Jul 11, 2026
Discovery of <b>DDO-4279</b> as a PP5 degrader for the treatment of obesity.

|Apr 15, 2026
Repurposing Ilaprazole as a PP5 TPR Domain Binder with Modulatory Effects on MAPK Signaling.

Yanyi He, Jinying Gu, Liwen Hua

|Jan 09, 2026
Discovery of (3<i>R</i>,4<i>R</i>)-15: An Advanced Factor B Inhibitor Entering Phase 3 for Complement-Mediated Diseases.

Changyou Ma, Jincai Su, Jiang Liu

|Nov 30, 2025
Targeting Cell division cycle 37: A Promising Novel Therapeutic Strategy.

Lixiao Zhang, Yuting Xin, Qidong You

|Sep 26, 2025
HSP90 Mediates Targeted Degradation of Nonclient Protein PARP1 for Breast Cancer Treatment.

Wei Liu, Jianfeng Liu, Huangliang Shu

|Sep 03, 2025
Small Molecules Targeting HSF1 Pathway: Chemical Strategies and Therapeutic Potential.

Caiyiren Wen, Yiqi Geng, Jiayue Pei

Pageof 5

Frequent Collaborators

25 joint publications

Qidong You

4 joint publications

Xiaoli Xu

4 joint publications

Qiuyue Zhang

3 joint publications

Ruoning Wang